Opportunity Information: Apply for RFA AG 24 029

The National Institutes of Health is offering this discretionary grant opportunity (RFA-AG-24-029) to support behavioral and social science research on how immigration shapes health across the life course for middle-aged and older adults, with explicit attention to health disparities and to Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). The focus is on first-generation immigrant populations in the United States, including Latino/a, Black, Asian, and other immigrant groups, and on understanding the pathways that help explain why health outcomes differ across groups as people age. The mechanism is an R21 (exploratory/developmental) and clinical trials are not allowed, signaling that the agency is looking for early-stage, innovative projects that may test new ideas, data resources, or analytic approaches rather than run intervention trials.

A central theme of the announcement is the idea that health in later life is shaped by layered influences that operate over time. The NOFO encourages studies that examine structural mechanisms (for example, immigration policy context, labor markets, discrimination, legal status-related constraints, access to health and social services, neighborhood segregation, and other institutional factors), community mechanisms (such as social cohesion, ethnic enclaves, community resources, and local service environments), and interpersonal mechanisms (including family dynamics, caregiving networks, social support, intergenerational relationships, and stress processes). The intention is to fund research that clarifies how these forces accumulate, interact, and produce measurable differences in health trajectories for immigrant groups as they move through midlife into older age.

In addition to general aging and health outcomes, the NOFO explicitly invites work that connects immigration experiences and contexts to cognitive aging and dementia outcomes, including AD/ADRD. This can include studies that tackle the practical and scientific challenges of doing immigration-focused AD/ADRD research, such as identifying appropriate data sources, improving measurement of immigration-related exposures (nativity, age at migration, duration in the US, documentation-related barriers, acculturation and language context, transnational ties), and addressing methodological issues that commonly arise in these populations. Examples of methodological needs implied by the NOFO include strategies for studying hard-to-reach groups, dealing with selection effects (who migrates and who remains), accounting for heterogeneous immigrant histories, improving culturally and linguistically appropriate cognitive measurement, and refining approaches to isolate the effects of immigration-related experiences from correlated socioeconomic and environmental factors.

This R21 announcement is described as a companion to RFA-AG-24-028, which uses the R01 mechanism. The agency is drawing a practical distinction between the two: projects with stronger preliminary data and readiness for a larger, more definitive study are steered toward the R01, while projects that are more exploratory, higher-risk/high-payoff, or earlier in development (and therefore may not yet have extensive preliminary findings) are framed as a better fit for this R21. In other words, this NOFO is positioned as a way to incubate new directions, generate foundational evidence, develop new measures or methods, or demonstrate feasibility that could later scale into larger R01-level work.

Key administrative details included in the source information are as follows. The funding instrument is a grant and the activity category is health (CFDA 93.866). The award ceiling is listed as $275,000. The original closing date shown is 2023-11-03. The expected number of awards is not specified in the provided text. Because it is an R21, applicants typically propose a tightly scoped project designed to produce a clear proof-of-concept, a novel dataset, a methodological advance, or initial findings that justify a subsequent larger study, while staying within the budget and time constraints associated with exploratory awards.

Eligibility is broad and includes many common applicant types: state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other Native American tribal organizations; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status; for-profit organizations (other than small businesses) and small businesses. The NOFO also highlights additional eligible applicant categories that NIH wants to encourage, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, eligible federal agencies, regional organizations, non-domestic (non-US) entities/foreign organizations, and US territories or possessions. This wide eligibility is consistent with the topic area, since meaningful immigration and aging research often benefits from partnerships that include community-based organizations, minority-serving institutions, and organizations serving immigrant communities.

Overall, the opportunity is aimed at strengthening the evidence base on how immigration-related experiences and contexts shape aging, health disparities, and dementia risk and outcomes, and at improving the data and methods needed to study these relationships rigorously. The R21 format is meant to give investigators room to pursue innovative questions and approaches that are not yet ready for a full-scale R01, while still producing actionable knowledge about mechanisms, measurement, and analytic strategies for understanding immigrant health and aging in the United States.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD?(R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
  • This funding opportunity was created on 2023-08-09.
  • Applicants must submit their applications by 2023-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $275,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AG 24 029

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)

Previous opportunity: Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AG 24 029

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AG 24 029) also looked into and applied for these:

Funding Opportunity
Community-Engaged Health Equity Research in Neuroscience Initiative (R34 CT Not Allowed) Apply for RFA NS 24 007

Funding Number: RFA NS 24 007
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neural and Non-Neural Mechanisms Underlying Gait as a Preclinical Marker for Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 24 041

Funding Number: RFA AG 24 041
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 24 042

Funding Number: RFA AG 24 042
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Planning for Product Development Strategy (R34 Clinical Trial Not Allowed) Apply for PAR 24 029

Funding Number: PAR 24 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
USAID Improved Maternal, Newborn, Child Health, Immunization and Nutrition Activity Apply for 72065623APS00001

Funding Number: 72065623APS00001
Agency: Mozambique USAID-Maputo
Category: Health
Funding Amount: $92,000,000
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD)?(U01 Clinical Trial Optional) Apply for PAR 23 258

Funding Number: PAR 23 258
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 24 043

Funding Number: RFA AG 24 043
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed) Apply for RFA NS 24 027

Funding Number: RFA NS 24 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25 Clinical Trial Not Allowed) Apply for RFA NS 23 030

Funding Number: RFA NS 23 030
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
AHRQ Improving Diagnostic Safety in Ambulatory Care: Strategies and Interventions (R18) Apply for PA 23 290

Funding Number: PA 23 290
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
AHRQ Understanding and Improving Diagnostic Safety in Ambulatory Care: Incidence and Contributing Factors (R01) Apply for PA 23 291

Funding Number: PA 23 291
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $500,000
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) Apply for PAR 23 274

Funding Number: PAR 23 274
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 24 046

Funding Number: RFA AG 24 046
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Improving Choice, Use, and Equitable Implementation of Biomedical HIV Prevention for Women (R34 Clinical Trial Optional) Apply for RFA MH 24 162

Funding Number: RFA MH 24 162
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA AG 24 027

Funding Number: RFA AG 24 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional) Apply for RFA RM 23 012

Funding Number: RFA RM 23 012
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Broadening Opportunities for Computational Genomics and Data Science Education (UE5 Clinical Trial Not Allowed) Apply for RFA HG 23 002

Funding Number: RFA HG 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional) Apply for RFA AG 24 031

Funding Number: RFA AG 24 031
Agency: National Institutes of Health
Category: Health
Funding Amount: $400,000
Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional) Apply for RFA AG 24 030

Funding Number: RFA AG 24 030
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,750,000
Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed) Apply for RFA DE 24 003

Funding Number: RFA DE 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 24 029", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: